logo
logo
Sign in
Sasha Sharma 2019-10-10
img

The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.On the basis of application, the digital therapeutics market is segmented into preventive and treatment/care-based applications.

On the basis of sales channel, the digital therapeutics market is segmented into B2C and B2B sales channel.

The B2B segment is estimated to command the largest share in 2016 and register the highest CAGR in the digital therapeutics market, by sales channel.

Factors such as growing awareness among providers, payers, and employers about the benefits of digital therapeutics and the growing inclination of pharmaceutical companies to integrate digital therapeutics with their drug products are driving the growth of this segment.Download PDF Brochure :https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics.

However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.Browse and in-depth TOC on "Digital Therapeutics Market"148 - Tables186 - Pages36 - FiguresOrder a copy of “Digital Therapeutics Market Size & Share | Industry Analysis” research study at: https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.aspThe key strategies followed by most companies in the digital therapeutics market are agreements, collaborations, and partnerships; investments; and new product launches.

Among all growth strategies adopted by market players, agreements, collaborations, and partnerships accounted for the largest share of the overall growth strategies mapped from 2013 to 2016.

collect
0
Sasha Sharma 2020-06-05
img

The global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period (2020–2025).

The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change (an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance.On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, unstable payment models, and resistance from traditional healthcare providers are challenging the growth of this market to a certain extent.Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724The Digital Therapeutic (DTx) Market is Segmented on:ApplicationSales ChannelB2B segment is expected to grow at the highest CAGR during the forecast periodBased on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B).

In 2019, the B2B segment accounted for the largest market share; it is also expected to grow at the highest CAGR of the digital therapeutics market.Caregivers segment is expected to dominate the marketBased on the type of buyer, the B2C sales channel market is further segmented into patients and caregivers.

The caregivers segment is expected to dominate the market and register the highest CAGR during the forecast period.

The high growth of this segment is attributed to company initiatives for the development of products specifically for caregivers and the fact that digital therapeutics help caregivers in better managing their patients.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724The treatment/care-related applications segment accounted for the largest share of the digital therapeutics market in 2019.Based on the application, the digital therapeutics market is segmented into preventive and treatment/care-related applications.

One of the key factors driving the growth of this segment is the rise in treatment and healthcare costs, especially due to chronic conditions.Regional Analysis:The global digital therapeutics market is segmented into North America, Europe, the Asia Pacific, and the RoW.

collect
0
Sasha Sharma 2020-11-27
img

According to research report, the global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period (2020–2025).The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change (an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724North America accounted for the largest share of the digital therapeutics market in 2019The global digital therapeutics market is segmented into North America, Europe, the Asia Pacific, and the RoW.

In 2019, North America (US and Canada) held the largest share of the market, followed by Europe.

The major factors supporting market growth include the increasing investments in digital therapeutics, the influx of new start-ups, improvements in the reimbursement structure for digital therapeutics, and government initiatives to support technological advancements.Get 10% FREE Customization on This Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=51646724Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B).

In 2019, the B2B segment accounted for the largest market share; it is also expected to grow at the highest CAGR of the digital therapeutics market.

There is growing awareness among providers, payers, and employers about the benefits provided by digital therapeutics and the healthcare cost reductions achieved by their use.Based on the type of buyer, the B2C sales channel market is further segmented into patients and caregivers.

The caregivers segment is expected to dominate the market and register the highest CAGR during the forecast period.

collect
0
saggy 2021-05-10

Digital Therapeutics Market - OverviewThe rising collaborations between digital therapeutics and pharma companies is motivating the market’s development.

Market reports associated with the healthcare industry have been made available by Market Research Future which creates reports on other industry verticals that outlines the current market scenarios.

The application of digital therapeutics is being increasingly leveraged to large-scale patient population and is expected to advance the healthcare outcomes substantially in the forecast period.Segmental AnalysisThe segmentation of the digital therapeutics market has been carried out on product type, application, and sales channel.

The regions included in the market analysis are Europe, North America, Asia Pacific, and the Rest of the World (RoW).Detailed Regional AnalysisThe regional analysis of the digital therapeutics market comprises of North America, Asia Pacific, Europe, and Rest of the World.

The North American region controls an important share of the market and is expected to hold its market share in the impending years.

The widespread existence of main players is expected to have an optimistic impact on the development of the regional market.

collect
0
Ruchita Roy 2021-02-17
img

Digital Therapeutics Market - OverviewThe rising collaborations between digital therapeutics and pharma companies is motivating the market’s development.

Market reports associated with the healthcare industry have been made available by Market Research Future which creates reports on other industry verticals that outlines the current market scenarios.

The application of digital therapeutics is being increasingly leveraged to large-scale patient population and is expected to advance the healthcare outcomes substantially in the forecast period.Segmental AnalysisThe segmentation of the digital therapeutics market has been carried out on product type, application, and sales channel.

The regions included in the market analysis are Europe, North America, Asia Pacific, and the Rest of the World (RoW).Detailed Regional Analysis The regional analysis of the digital therapeutics market comprises of North America, Asia Pacific, Europe, and Rest of the World.

The North American region controls an important share of the market and is expected to hold its market share in the impending years.

The widespread existence of main players is expected to have an optimistic impact on the development of the regional market.

collect
0
Rohit Kamble 2020-02-19
img

Global Digital Therapeutics Market Size is an ever growing and expanding market and encompasses a multitude of current medical devices and technologies.

According to Market Research Future (MRFR), the global Digital Therapeutics Market Size is poised for considerable growth over the forecast period.The market is in its early stage and has been expanding on account of realization of incorporating digital elements into traditional medical devices.

Apart from that, various factors are responsible for increasing the traction of digital therapeutics products.Global Digital Therapeutics Market Size Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making.

This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability.

It provides information on trends and developments, and focuses on Markets and materials, capacities and technologies, and on the changing structure of the Serotonin Supplements Market.Some of the key players operating for the global market analysis are Twine Health Inc., Proteus Digital Health, Inc., Mango Health, Inc., Propeller Health, Canary Health Inc., Medtronic Plc., Noom Inc, WellDoc Inc., Omada Health, Inc., and Livongo Health.Digital Therapeutics Market Size Research Coverage:Changing market dynamics of the industryTo get a comprehensive overview of the Digital Therapeutics Market Size.Historical, current and projected market size in terms of volume and valueIn-depth market segmentationCompetitive landscapeThe report presents an all-inclusive database in a systematic and highly comprehensive manner.

It intends to offer valid, factual, reliable, and easily understandable information about the which makes it more eloquent.

collect
0
Sasha Sharma 2019-10-14
img

 According to the new market research report " Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", published by MarketsandMarkets™, The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.Download PDF Brochure :https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics.

However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.Browse and in-depth TOC on "Digital Therapeutics Market"148 - Tables186 - Pages36 - FiguresOrder a copy of “Digital Therapeutics Market Size & Share | Industry Analysis” research study at:https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.aspThe digital therapeutics market is highly fragmented, diversified, and increasingly competitive, with a large number of small players competing for market space, including startup firms.

Each segment has different market players and market leaders.

For instance, the prediabetes market was led by Omada in 2015.

Omada Health is a leading provider of digital therapeutics for preventable type 2 diabetes and heart disease.

Omada’s product portfolio consists of ‘Prevent’, an online diabetes prevention program.

collect
0
Avani Sable 2020-02-27

The global mHealth market size is expected to reach USD 293.29 billion by 2026, exhibiting a CAGR of 29.1% during the forecast period.

The increasing penetration of smartphones and smart devices will boost the mHealth market trends during the forecast period.

While roughly three-quarters of U.S. adults own desktop or laptop computers, furthermore, the launch of technologically advanced smartphones and wearable devices will consequently aid the mHealth market share, sates our lead analysts at Fortune Business Insights.

For instance, OnePlus launched a new concept phone, the OnePlus Concept One McLaren Edition has various features including electrochromic glass technology.

In addition, Fitbit CEO James said in a statement, “We see ourselves evenly split between being a consumer company and being a health company.”For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/mhealth-market-100266According to the report, published by Fortune Business Insights in a report, titled “mHealth Market Size, Share & Industry Analysis, By Category (By Apps {Disease & Treatment Management, Wellness Management}, By Wearable {Body & Temperature Monitors, Sleep Trackers, Fitness Trackers, Glucose Monitors, BP Monitors, Cardiac Monitors}) By Services Type (Monitoring Services, Fitness & Wellness Solutions, Diagnostic Services, Treatment Services) By Service Provider (mHealth App Companies, Pharmaceutical Companies, Hospitals, Health Insurance) and Regional Forecast, 2019-2026” the market size stood at USD 34.28 billion in 2018.

The mHealth market report implements a PESTEL study and SWOT analysis to reveal the stability, restrictions, openings, and threats in the smart building market.

collect
0
Report Banana 2021-09-14
img

Publisher: Allied Market ResearchPR Title 1: The digital therapeutics market is expected to reach $7,833 million by 2025 with CAGR of 20.5%According to new report added in Report Banana offerings, there are significant money making opportunities available in the digital therapeutics market.

Companies planning to enter this market need to prepare and differentiate to maximize their return on investment.In terms of opportunities, the digital therapeutics market is expected to grow from $1,751 million in 2017 to USD 7,833 million by 2025; it is expected to grow at a CAGR of 20.5% during the forecast period.Increase in adoption of smartphones & tablets coupled with rise in utilization of healthcare apps is the major factor that drives the growth of the global digital therapeutics market.

In addition, increasing need to control healthcare costs supplements the market growth.Digital therapeutics is a type of treatment option, which utilizes online health technologies and digital devices to treat numerous medical conditions and help maintain health discipline.Prominent players profiled in this report include Proteus Digital Health, Inc., Omada Health, Inc., Welldoc, Inc., Morrow Inc., Livongo Health, Propeller Health, Twine Health, Inc. (Fitbit Inc.), Canary Health, Inc., Noom Inc., Medtronic Plc, etc.Significant Aspects of the Report and Main Highlights:Changing business trends in the digital therapeutics marketMarket segment analysis at different level such as application, product, sales channel, and regionHistorical and forecast size of the digital therapeutics market in terms of revenueMajor drivers and opportunities pertaining to the digital therapeutics marketCompetitive landscape and player positioning analysis for the marketKey product offerings by major players and business strategies adoptedKey challenges faced by operating players in the market spaceAnalysis of major risks associated with the market operationsThe report helps stakeholders understand the pulse of the market and provides them with information on key drivers, restraints, challenges, and opportunities for market growth.

It would also help to understand the competitors better and gain more insights to improve their position in the business.To read more about this market please click on https://www.reportbanana.com/-digital-therapeutics-market-by-application-diabet-rpt40568.aspxContact Us at:Phone:      +1 469 638 2694 (US)                 +31-6-82270883 (Europe)                 +91-771-4288410 (Asia)Email: [email protected] About Report BananaReport Banana provides syndicated as well as customized market research reports from various market research companies around the globe.

Our product offerings register presence in most of the verticals such as aerospace, automotive, chemical, construction, consumer, E, medical, and service industries.

For further information, visit www.reportbanana.com

collect
0
Sasha Sharma 2019-07-05
img

According to the new market research report " Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", published by MarketsandMarkets™, The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics.

However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.Browse and in-depth TOC on "Digital Therapeutics Market" 148  - Tables186 - Pages36  - Figures Order a copy of “Digital Therapeutics Market Size & Share | Industry Analysis” research study at:https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.aspThe digital therapeutics market is highly fragmented, diversified, and increasingly competitive, with a large number of small players competing for market space, including startup firms.

Each segment has different market players and market leaders.

For instance, the prediabetes market was led by Omada in 2015.

Omada Health is a leading provider of digital therapeutics for preventable type 2 diabetes and heart disease.

Omada’s product portfolio consists of ‘Prevent’, an online diabetes prevention program.

collect
0
Ruchita Roy 2021-03-08
img

Digital Therapeutics Market - OverviewThe rising collaborations between digital therapeutics and pharma companies is motivating the market’s development.

Market reports associated with the healthcare industry have been made available by Market Research Future which creates reports on other industry verticals that outlines the current market scenarios.

On the basis of application, the market has been segmented into cardiovascular diseases, obesity, diabetes, respiratory diseases, smoking cessation, and others.

Detailed Regional Analysis The regional analysis of the digital therapeutics market comprises of North America, Asia Pacific, Europe, and Rest of the World.

The North American region controls an important share of the market and is expected to hold its market share in the impending years.

The widespread existence of main players is expected to have an optimistic impact on the development of the regional market.

collect
0
Sasha Sharma 2020-05-13
img

Rising healthcare costs, the growing prevalence of chronic diseases, and the ability of digital therapeutics to provide cost-effective solutions are some factors responsible for driving the market for treatment/care-related digital therapeutics applications.The global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period (2020–2025).The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change (an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance.The Digital Therapeutic (DTx) Market is Segmented on:1.

Sales ChannelBrowse 134  market data Tables and 27 Figures spread through 166 Pages.Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=516467241B2B segment is expected to grow at the highest CAGR during the forecast periodBased on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B).

In 2019, the B2B segment accounted for the largest market share; it is also expected to grow at the highest CAGR of the digital therapeutics market.Caregivers segment is expected to dominate the marketBased on the type of buyer, the B2C sales channel market is further segmented into patients and caregivers.

The caregivers segment is expected to dominate the market and register the highest CAGR during the forecast period.

The high growth of this segment is attributed to company initiatives for the development of products specifically for caregivers and the fact that digital therapeutics help caregivers in better managing their patients.Regional Growth, Development and Demand Analysis:The global digital therapeutics market is segmented into North America, Europe, the Asia Pacific, and the RoW.

In 2019, North America (US and Canada) held the largest share of the market, followed by Europe.

collect
0
[email protected] rashipande23 2019-12-24

Market Analysis:  Global Digital Therapeutics Systems MarketGlobal Digital Therapeutics Systems Market is expected to rise from its initial estimated value of USD 198.03 million in 2018 to an estimated value of USD 1,365.70 million by 2026 registering a CAGR of 27.3% in the forecast period of 2019-2026.

This rise in the market can be attributed to the rising geriatric population over the world and pro-active government policies to support the improvement and application of digital therapeutics solutions.Few of the major market competitors currently working in global digital therapeutics market are Proteus Digital Health, Omada Health, Inc., WellDoc, Inc., 2Morrow Inc., Livongo Health, Propeller Health, Fitbit Health Solutions, CANARY HEALTH, Noom, Inc., Medtronic, Biogen, MindSciences, JINTRONIX, Virta Health Corp, and Dthera Sciences.Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-digital-therapeutics-marketMarket Definition:  Global Digital Therapeutics Systems MarketDigital therapeutic is a technology based health solution.

This system utilizes digital and online health technologies for the treatment of various medical and psychological conditions.

This is basically a type of app which helps patients and physicians to constant monitor the health data by modifying patient behavior and provides remote monitoring in order to improve the patients long-term health problems.

This is a cost effective solution and also have the potential to improve patient engagement and bring substantial change in patient health.

This treatment solution is basically used to help and mange long term medical conditions which include asthma, insomnia, and diabetes.Market DriversGrowing Focus on Preventive Healthcare is driving the marketTechnological advancements in the industry will act as a major market driverMarket Restraintslack of awareness among the population is restraining the growthPatient data confidentiality concerns is another restraint for the marketSegmentation:  Global Digital Therapeutics Systems MarketBy ProductPain Management DevicesRehabilitation DevicesRespiratory Therapy DevicesInsulin PumpsBy ApplicationPreventivePre DiabetesObesitySmoking CessationTreatment/CareDiabetesCardiovascular DiseasesCentral Nervous System DiseaseRespiratory DiseasesMusculoskeletal DiseasesMedication AdherenceBy Sales ChannelBusiness-to-Consumer (B2C)PatientCaregiverBusiness-to-Business (B2B)ProvidersPayersEmployersPharmaceutical CompaniesBy GeographyNorth AmericaUSCanadaMexicoSouth AmericaBrazilArgentinaRest of South AmericaEuropeGermanyFranceUnited KingdomItalySpainRussiaTurkeyBelgiumNetherlandsSwitzerlandRest of EuropeAsia-PacificJapanChinaSouth KoreaIndiaAustraliaSingaporeMalaysiaIndonesiaThailandPhilippinesRest of Asia-PacificMiddle East and AfricaSouth AfricaEgyptSaudi ArabiaUnited Arab EmiratesIsraelRest of Middle East and AfricaGet TOC of Full Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-digital-therapeutics-marketKey Developments in the Market:In September, 2018, Fitbit has launched Fitbit Care.

collect
0
shriya laturkar 2021-08-24
img

Digital Therapeutics Market Research Analysis By Product Type (Software, Devices And Others), Application (Cardiovascular Diseases, Obesity, Diabetes, Respiratory Diseases, Smoking Cessation and Others) and Sales Channel (B2B and B2C) and End Users - Global Forecast 2027Digital Therapeutics Market– OverviewThe rising collaborations between digital therapeutics and pharma companies is motivating the market’s development.

The application of digital therapeutics is being increasingly leveraged to large-scale patient population and is expected to advance the healthcare outcomes substantially in the forecast period.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6492 Segmental AnalysisThe segmentation of the digital therapeutics market has been carried out on product type, application, and sales channel.

The regions included in the market analysis are Europe, North America, Asia Pacific, and the Rest of the World (RoW).Detailed Regional Analysis The regional analysis of the digital therapeutics market comprises of North America, Asia Pacific, Europe, and Rest of the World.

The North American region controls an important share of the market and is expected to hold its market share in the impending years.

The widespread existence of main players is expected to have an optimistic impact on the development of the regional market.

The factors such as enhanced adoption of next-gen healthcare technology, expansion in the healthcare sector, increasing elderly population, etc.

collect
0
komal waghmare 2021-01-22

Summary – A new market study, “Global Digital Therapeutics Market Size, Status and Forecast 2020-2026” has been featured on WiseGuyReports.Digital Therapeutics market is segmented by Type, and by Application.

Players, stakeholders, and other participants in the global Digital Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource.

The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.ALSO READ : https://www.medgadget.com/2020/03/digital-therapeutics-market-2020-global-industry-key-players-size-trends-opportunities-growth-analysis-to-2026.htmlThe key players covered in this studyProteus Digital HealthOmada HealthWellDoc2MorrowALSO READ : https://www.openpr.com/news/2112619/global-luxury-vehicles-market-2020-key-vendors-trendsLivongo HealthPropeller HealthTwine HealthCanary HealthALSO READ : http://www.marketwatch.com/story/global-natural-shampooorganic-shampoo-market-2020-segmentation-demand-growth-trend-opportunity-and-forecast-to-2026-2020-12-18Market segment by Type, the product can be split intoSoftwareDevicesMarket segment by Application, split intoDiabetesObesityALSO READ : http://www.marketwatch.com/story/global-ar-and-vr-software-market-2020-segmentation-demand-growth-trend-opportunity-and-forecast-to-2025-2020-11-10Cardio Vascular Diseases (CVD)Central Nervous System (CNS) DiseaseGastrointestinal Disorders (GID)Respiratory DiseasesSmoking CessationOthersALSO READ : http://www.marketwatch.com/story/global-testing-inspection-and-certification-tic-for-agriculture-market-2020-key-vendors-trends-analysis-segmentation-forecast-to-2025-2020-10-14Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South AmericaAbout Us:Wise Guy Reports is part of the Wise Guy Research Consultants Pvt.

Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Contact Us:NORAH TRENT                                                     [email protected]      Ph: +162-825-80070 (US)                         Ph: +44 2026002763 (UK) 

collect
0
Sasha Sharma 2019-06-13
img

According to the new market research report " Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", published by MarketsandMarkets™, The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.Get Sample Copy for more Professional and Technical insights at : https://www.marketsandmarkets.com/ResearchInsight/digital-therapeutics-market.aspThe factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics.

However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.Browse and in-depth TOC on "Digital Therapeutics Market" 148  - Tables36  - Figures Order a copy of “Digital Therapeutics Market Size & Share | Industry Analysis” research study at:https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.asp The digital therapeutics market is highly fragmented, diversified, and increasingly competitive, with a large number of small players competing for market space, including startup firms.

Each segment has different market players and market leaders.

For instance, the prediabetes market was led by Omada in 2015.

Omada Health is a leading provider of digital therapeutics for preventable type 2 diabetes and heart disease.

Omada’s product portfolio consists of ‘Prevent’, an online diabetes prevention program.

collect
0
Sasha Sharma 2019-10-10
img

The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.On the basis of application, the digital therapeutics market is segmented into preventive and treatment/care-based applications.

On the basis of sales channel, the digital therapeutics market is segmented into B2C and B2B sales channel.

The B2B segment is estimated to command the largest share in 2016 and register the highest CAGR in the digital therapeutics market, by sales channel.

Factors such as growing awareness among providers, payers, and employers about the benefits of digital therapeutics and the growing inclination of pharmaceutical companies to integrate digital therapeutics with their drug products are driving the growth of this segment.Download PDF Brochure :https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics.

However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.Browse and in-depth TOC on "Digital Therapeutics Market"148 - Tables186 - Pages36 - FiguresOrder a copy of “Digital Therapeutics Market Size & Share | Industry Analysis” research study at: https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.aspThe key strategies followed by most companies in the digital therapeutics market are agreements, collaborations, and partnerships; investments; and new product launches.

Among all growth strategies adopted by market players, agreements, collaborations, and partnerships accounted for the largest share of the overall growth strategies mapped from 2013 to 2016.

Sasha Sharma 2020-11-27
img

According to research report, the global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period (2020–2025).The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change (an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724North America accounted for the largest share of the digital therapeutics market in 2019The global digital therapeutics market is segmented into North America, Europe, the Asia Pacific, and the RoW.

In 2019, North America (US and Canada) held the largest share of the market, followed by Europe.

The major factors supporting market growth include the increasing investments in digital therapeutics, the influx of new start-ups, improvements in the reimbursement structure for digital therapeutics, and government initiatives to support technological advancements.Get 10% FREE Customization on This Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=51646724Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B).

In 2019, the B2B segment accounted for the largest market share; it is also expected to grow at the highest CAGR of the digital therapeutics market.

There is growing awareness among providers, payers, and employers about the benefits provided by digital therapeutics and the healthcare cost reductions achieved by their use.Based on the type of buyer, the B2C sales channel market is further segmented into patients and caregivers.

The caregivers segment is expected to dominate the market and register the highest CAGR during the forecast period.

Ruchita Roy 2021-02-17
img

Digital Therapeutics Market - OverviewThe rising collaborations between digital therapeutics and pharma companies is motivating the market’s development.

Market reports associated with the healthcare industry have been made available by Market Research Future which creates reports on other industry verticals that outlines the current market scenarios.

The application of digital therapeutics is being increasingly leveraged to large-scale patient population and is expected to advance the healthcare outcomes substantially in the forecast period.Segmental AnalysisThe segmentation of the digital therapeutics market has been carried out on product type, application, and sales channel.

The regions included in the market analysis are Europe, North America, Asia Pacific, and the Rest of the World (RoW).Detailed Regional Analysis The regional analysis of the digital therapeutics market comprises of North America, Asia Pacific, Europe, and Rest of the World.

The North American region controls an important share of the market and is expected to hold its market share in the impending years.

The widespread existence of main players is expected to have an optimistic impact on the development of the regional market.

Sasha Sharma 2019-10-14
img

 According to the new market research report " Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", published by MarketsandMarkets™, The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.Download PDF Brochure :https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics.

However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.Browse and in-depth TOC on "Digital Therapeutics Market"148 - Tables186 - Pages36 - FiguresOrder a copy of “Digital Therapeutics Market Size & Share | Industry Analysis” research study at:https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.aspThe digital therapeutics market is highly fragmented, diversified, and increasingly competitive, with a large number of small players competing for market space, including startup firms.

Each segment has different market players and market leaders.

For instance, the prediabetes market was led by Omada in 2015.

Omada Health is a leading provider of digital therapeutics for preventable type 2 diabetes and heart disease.

Omada’s product portfolio consists of ‘Prevent’, an online diabetes prevention program.

Report Banana 2021-09-14
img

Publisher: Allied Market ResearchPR Title 1: The digital therapeutics market is expected to reach $7,833 million by 2025 with CAGR of 20.5%According to new report added in Report Banana offerings, there are significant money making opportunities available in the digital therapeutics market.

Companies planning to enter this market need to prepare and differentiate to maximize their return on investment.In terms of opportunities, the digital therapeutics market is expected to grow from $1,751 million in 2017 to USD 7,833 million by 2025; it is expected to grow at a CAGR of 20.5% during the forecast period.Increase in adoption of smartphones & tablets coupled with rise in utilization of healthcare apps is the major factor that drives the growth of the global digital therapeutics market.

In addition, increasing need to control healthcare costs supplements the market growth.Digital therapeutics is a type of treatment option, which utilizes online health technologies and digital devices to treat numerous medical conditions and help maintain health discipline.Prominent players profiled in this report include Proteus Digital Health, Inc., Omada Health, Inc., Welldoc, Inc., Morrow Inc., Livongo Health, Propeller Health, Twine Health, Inc. (Fitbit Inc.), Canary Health, Inc., Noom Inc., Medtronic Plc, etc.Significant Aspects of the Report and Main Highlights:Changing business trends in the digital therapeutics marketMarket segment analysis at different level such as application, product, sales channel, and regionHistorical and forecast size of the digital therapeutics market in terms of revenueMajor drivers and opportunities pertaining to the digital therapeutics marketCompetitive landscape and player positioning analysis for the marketKey product offerings by major players and business strategies adoptedKey challenges faced by operating players in the market spaceAnalysis of major risks associated with the market operationsThe report helps stakeholders understand the pulse of the market and provides them with information on key drivers, restraints, challenges, and opportunities for market growth.

It would also help to understand the competitors better and gain more insights to improve their position in the business.To read more about this market please click on https://www.reportbanana.com/-digital-therapeutics-market-by-application-diabet-rpt40568.aspxContact Us at:Phone:      +1 469 638 2694 (US)                 +31-6-82270883 (Europe)                 +91-771-4288410 (Asia)Email: [email protected] About Report BananaReport Banana provides syndicated as well as customized market research reports from various market research companies around the globe.

Our product offerings register presence in most of the verticals such as aerospace, automotive, chemical, construction, consumer, E, medical, and service industries.

For further information, visit www.reportbanana.com

Ruchita Roy 2021-03-08
img

Digital Therapeutics Market - OverviewThe rising collaborations between digital therapeutics and pharma companies is motivating the market’s development.

Market reports associated with the healthcare industry have been made available by Market Research Future which creates reports on other industry verticals that outlines the current market scenarios.

On the basis of application, the market has been segmented into cardiovascular diseases, obesity, diabetes, respiratory diseases, smoking cessation, and others.

Detailed Regional Analysis The regional analysis of the digital therapeutics market comprises of North America, Asia Pacific, Europe, and Rest of the World.

The North American region controls an important share of the market and is expected to hold its market share in the impending years.

The widespread existence of main players is expected to have an optimistic impact on the development of the regional market.

[email protected] rashipande23 2019-12-24

Market Analysis:  Global Digital Therapeutics Systems MarketGlobal Digital Therapeutics Systems Market is expected to rise from its initial estimated value of USD 198.03 million in 2018 to an estimated value of USD 1,365.70 million by 2026 registering a CAGR of 27.3% in the forecast period of 2019-2026.

This rise in the market can be attributed to the rising geriatric population over the world and pro-active government policies to support the improvement and application of digital therapeutics solutions.Few of the major market competitors currently working in global digital therapeutics market are Proteus Digital Health, Omada Health, Inc., WellDoc, Inc., 2Morrow Inc., Livongo Health, Propeller Health, Fitbit Health Solutions, CANARY HEALTH, Noom, Inc., Medtronic, Biogen, MindSciences, JINTRONIX, Virta Health Corp, and Dthera Sciences.Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-digital-therapeutics-marketMarket Definition:  Global Digital Therapeutics Systems MarketDigital therapeutic is a technology based health solution.

This system utilizes digital and online health technologies for the treatment of various medical and psychological conditions.

This is basically a type of app which helps patients and physicians to constant monitor the health data by modifying patient behavior and provides remote monitoring in order to improve the patients long-term health problems.

This is a cost effective solution and also have the potential to improve patient engagement and bring substantial change in patient health.

This treatment solution is basically used to help and mange long term medical conditions which include asthma, insomnia, and diabetes.Market DriversGrowing Focus on Preventive Healthcare is driving the marketTechnological advancements in the industry will act as a major market driverMarket Restraintslack of awareness among the population is restraining the growthPatient data confidentiality concerns is another restraint for the marketSegmentation:  Global Digital Therapeutics Systems MarketBy ProductPain Management DevicesRehabilitation DevicesRespiratory Therapy DevicesInsulin PumpsBy ApplicationPreventivePre DiabetesObesitySmoking CessationTreatment/CareDiabetesCardiovascular DiseasesCentral Nervous System DiseaseRespiratory DiseasesMusculoskeletal DiseasesMedication AdherenceBy Sales ChannelBusiness-to-Consumer (B2C)PatientCaregiverBusiness-to-Business (B2B)ProvidersPayersEmployersPharmaceutical CompaniesBy GeographyNorth AmericaUSCanadaMexicoSouth AmericaBrazilArgentinaRest of South AmericaEuropeGermanyFranceUnited KingdomItalySpainRussiaTurkeyBelgiumNetherlandsSwitzerlandRest of EuropeAsia-PacificJapanChinaSouth KoreaIndiaAustraliaSingaporeMalaysiaIndonesiaThailandPhilippinesRest of Asia-PacificMiddle East and AfricaSouth AfricaEgyptSaudi ArabiaUnited Arab EmiratesIsraelRest of Middle East and AfricaGet TOC of Full Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-digital-therapeutics-marketKey Developments in the Market:In September, 2018, Fitbit has launched Fitbit Care.

komal waghmare 2021-01-22

Summary – A new market study, “Global Digital Therapeutics Market Size, Status and Forecast 2020-2026” has been featured on WiseGuyReports.Digital Therapeutics market is segmented by Type, and by Application.

Players, stakeholders, and other participants in the global Digital Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource.

The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.ALSO READ : https://www.medgadget.com/2020/03/digital-therapeutics-market-2020-global-industry-key-players-size-trends-opportunities-growth-analysis-to-2026.htmlThe key players covered in this studyProteus Digital HealthOmada HealthWellDoc2MorrowALSO READ : https://www.openpr.com/news/2112619/global-luxury-vehicles-market-2020-key-vendors-trendsLivongo HealthPropeller HealthTwine HealthCanary HealthALSO READ : http://www.marketwatch.com/story/global-natural-shampooorganic-shampoo-market-2020-segmentation-demand-growth-trend-opportunity-and-forecast-to-2026-2020-12-18Market segment by Type, the product can be split intoSoftwareDevicesMarket segment by Application, split intoDiabetesObesityALSO READ : http://www.marketwatch.com/story/global-ar-and-vr-software-market-2020-segmentation-demand-growth-trend-opportunity-and-forecast-to-2025-2020-11-10Cardio Vascular Diseases (CVD)Central Nervous System (CNS) DiseaseGastrointestinal Disorders (GID)Respiratory DiseasesSmoking CessationOthersALSO READ : http://www.marketwatch.com/story/global-testing-inspection-and-certification-tic-for-agriculture-market-2020-key-vendors-trends-analysis-segmentation-forecast-to-2025-2020-10-14Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South AmericaAbout Us:Wise Guy Reports is part of the Wise Guy Research Consultants Pvt.

Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Contact Us:NORAH TRENT                                                     [email protected]      Ph: +162-825-80070 (US)                         Ph: +44 2026002763 (UK) 

Sasha Sharma 2020-06-05
img

The global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period (2020–2025).

The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change (an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance.On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, unstable payment models, and resistance from traditional healthcare providers are challenging the growth of this market to a certain extent.Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724The Digital Therapeutic (DTx) Market is Segmented on:ApplicationSales ChannelB2B segment is expected to grow at the highest CAGR during the forecast periodBased on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B).

In 2019, the B2B segment accounted for the largest market share; it is also expected to grow at the highest CAGR of the digital therapeutics market.Caregivers segment is expected to dominate the marketBased on the type of buyer, the B2C sales channel market is further segmented into patients and caregivers.

The caregivers segment is expected to dominate the market and register the highest CAGR during the forecast period.

The high growth of this segment is attributed to company initiatives for the development of products specifically for caregivers and the fact that digital therapeutics help caregivers in better managing their patients.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724The treatment/care-related applications segment accounted for the largest share of the digital therapeutics market in 2019.Based on the application, the digital therapeutics market is segmented into preventive and treatment/care-related applications.

One of the key factors driving the growth of this segment is the rise in treatment and healthcare costs, especially due to chronic conditions.Regional Analysis:The global digital therapeutics market is segmented into North America, Europe, the Asia Pacific, and the RoW.

saggy 2021-05-10

Digital Therapeutics Market - OverviewThe rising collaborations between digital therapeutics and pharma companies is motivating the market’s development.

Market reports associated with the healthcare industry have been made available by Market Research Future which creates reports on other industry verticals that outlines the current market scenarios.

The application of digital therapeutics is being increasingly leveraged to large-scale patient population and is expected to advance the healthcare outcomes substantially in the forecast period.Segmental AnalysisThe segmentation of the digital therapeutics market has been carried out on product type, application, and sales channel.

The regions included in the market analysis are Europe, North America, Asia Pacific, and the Rest of the World (RoW).Detailed Regional AnalysisThe regional analysis of the digital therapeutics market comprises of North America, Asia Pacific, Europe, and Rest of the World.

The North American region controls an important share of the market and is expected to hold its market share in the impending years.

The widespread existence of main players is expected to have an optimistic impact on the development of the regional market.

Rohit Kamble 2020-02-19
img

Global Digital Therapeutics Market Size is an ever growing and expanding market and encompasses a multitude of current medical devices and technologies.

According to Market Research Future (MRFR), the global Digital Therapeutics Market Size is poised for considerable growth over the forecast period.The market is in its early stage and has been expanding on account of realization of incorporating digital elements into traditional medical devices.

Apart from that, various factors are responsible for increasing the traction of digital therapeutics products.Global Digital Therapeutics Market Size Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making.

This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability.

It provides information on trends and developments, and focuses on Markets and materials, capacities and technologies, and on the changing structure of the Serotonin Supplements Market.Some of the key players operating for the global market analysis are Twine Health Inc., Proteus Digital Health, Inc., Mango Health, Inc., Propeller Health, Canary Health Inc., Medtronic Plc., Noom Inc, WellDoc Inc., Omada Health, Inc., and Livongo Health.Digital Therapeutics Market Size Research Coverage:Changing market dynamics of the industryTo get a comprehensive overview of the Digital Therapeutics Market Size.Historical, current and projected market size in terms of volume and valueIn-depth market segmentationCompetitive landscapeThe report presents an all-inclusive database in a systematic and highly comprehensive manner.

It intends to offer valid, factual, reliable, and easily understandable information about the which makes it more eloquent.

Avani Sable 2020-02-27

The global mHealth market size is expected to reach USD 293.29 billion by 2026, exhibiting a CAGR of 29.1% during the forecast period.

The increasing penetration of smartphones and smart devices will boost the mHealth market trends during the forecast period.

While roughly three-quarters of U.S. adults own desktop or laptop computers, furthermore, the launch of technologically advanced smartphones and wearable devices will consequently aid the mHealth market share, sates our lead analysts at Fortune Business Insights.

For instance, OnePlus launched a new concept phone, the OnePlus Concept One McLaren Edition has various features including electrochromic glass technology.

In addition, Fitbit CEO James said in a statement, “We see ourselves evenly split between being a consumer company and being a health company.”For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/mhealth-market-100266According to the report, published by Fortune Business Insights in a report, titled “mHealth Market Size, Share & Industry Analysis, By Category (By Apps {Disease & Treatment Management, Wellness Management}, By Wearable {Body & Temperature Monitors, Sleep Trackers, Fitness Trackers, Glucose Monitors, BP Monitors, Cardiac Monitors}) By Services Type (Monitoring Services, Fitness & Wellness Solutions, Diagnostic Services, Treatment Services) By Service Provider (mHealth App Companies, Pharmaceutical Companies, Hospitals, Health Insurance) and Regional Forecast, 2019-2026” the market size stood at USD 34.28 billion in 2018.

The mHealth market report implements a PESTEL study and SWOT analysis to reveal the stability, restrictions, openings, and threats in the smart building market.

Sasha Sharma 2019-07-05
img

According to the new market research report " Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", published by MarketsandMarkets™, The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics.

However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.Browse and in-depth TOC on "Digital Therapeutics Market" 148  - Tables186 - Pages36  - Figures Order a copy of “Digital Therapeutics Market Size & Share | Industry Analysis” research study at:https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.aspThe digital therapeutics market is highly fragmented, diversified, and increasingly competitive, with a large number of small players competing for market space, including startup firms.

Each segment has different market players and market leaders.

For instance, the prediabetes market was led by Omada in 2015.

Omada Health is a leading provider of digital therapeutics for preventable type 2 diabetes and heart disease.

Omada’s product portfolio consists of ‘Prevent’, an online diabetes prevention program.

Sasha Sharma 2020-05-13
img

Rising healthcare costs, the growing prevalence of chronic diseases, and the ability of digital therapeutics to provide cost-effective solutions are some factors responsible for driving the market for treatment/care-related digital therapeutics applications.The global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period (2020–2025).The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change (an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance.The Digital Therapeutic (DTx) Market is Segmented on:1.

Sales ChannelBrowse 134  market data Tables and 27 Figures spread through 166 Pages.Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=516467241B2B segment is expected to grow at the highest CAGR during the forecast periodBased on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B).

In 2019, the B2B segment accounted for the largest market share; it is also expected to grow at the highest CAGR of the digital therapeutics market.Caregivers segment is expected to dominate the marketBased on the type of buyer, the B2C sales channel market is further segmented into patients and caregivers.

The caregivers segment is expected to dominate the market and register the highest CAGR during the forecast period.

The high growth of this segment is attributed to company initiatives for the development of products specifically for caregivers and the fact that digital therapeutics help caregivers in better managing their patients.Regional Growth, Development and Demand Analysis:The global digital therapeutics market is segmented into North America, Europe, the Asia Pacific, and the RoW.

In 2019, North America (US and Canada) held the largest share of the market, followed by Europe.

shriya laturkar 2021-08-24
img

Digital Therapeutics Market Research Analysis By Product Type (Software, Devices And Others), Application (Cardiovascular Diseases, Obesity, Diabetes, Respiratory Diseases, Smoking Cessation and Others) and Sales Channel (B2B and B2C) and End Users - Global Forecast 2027Digital Therapeutics Market– OverviewThe rising collaborations between digital therapeutics and pharma companies is motivating the market’s development.

The application of digital therapeutics is being increasingly leveraged to large-scale patient population and is expected to advance the healthcare outcomes substantially in the forecast period.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6492 Segmental AnalysisThe segmentation of the digital therapeutics market has been carried out on product type, application, and sales channel.

The regions included in the market analysis are Europe, North America, Asia Pacific, and the Rest of the World (RoW).Detailed Regional Analysis The regional analysis of the digital therapeutics market comprises of North America, Asia Pacific, Europe, and Rest of the World.

The North American region controls an important share of the market and is expected to hold its market share in the impending years.

The widespread existence of main players is expected to have an optimistic impact on the development of the regional market.

The factors such as enhanced adoption of next-gen healthcare technology, expansion in the healthcare sector, increasing elderly population, etc.

Sasha Sharma 2019-06-13
img

According to the new market research report " Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", published by MarketsandMarkets™, The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.Get Sample Copy for more Professional and Technical insights at : https://www.marketsandmarkets.com/ResearchInsight/digital-therapeutics-market.aspThe factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics.

However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.Browse and in-depth TOC on "Digital Therapeutics Market" 148  - Tables36  - Figures Order a copy of “Digital Therapeutics Market Size & Share | Industry Analysis” research study at:https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.asp The digital therapeutics market is highly fragmented, diversified, and increasingly competitive, with a large number of small players competing for market space, including startup firms.

Each segment has different market players and market leaders.

For instance, the prediabetes market was led by Omada in 2015.

Omada Health is a leading provider of digital therapeutics for preventable type 2 diabetes and heart disease.

Omada’s product portfolio consists of ‘Prevent’, an online diabetes prevention program.

1 of 6